Hariprasad Gali to Male
This is a "connection" page, showing publications Hariprasad Gali has written about Male.
Connection Strength
0.147
-
Evaluation of [ยน8F]PFH PET renography to predict future disease progression in a rat model of autosomal dominant polycystic kidney disease. Nucl Med Biol. 2016 Jan; 43(1):1-5.
Score: 0.042
-
Evaluation of (99m)Tc-probestin SPECT as a novel technique for noninvasive imaging of kidney aminopeptidase N expression. Mol Pharm. 2014 Aug 04; 11(8):2948-53.
Score: 0.039
-
PET Detection of Cerebral Necrosis Using an Infarct-Avid Agent 2-Deoxy-2-[18F]Fluoro-D-Glucaric Acid (FGA) in a Mouse Model of the Brain Stroke. Mol Imaging Biol. 2020 10; 22(5):1353-1361.
Score: 0.015
-
Nanoparticles for Targeting of Prostate Cancer. Curr Pharm Des. 2020; 26(42):5393-5413.
Score: 0.014
-
A "dose on demand" Biomarker Generator for automated production of [(18)F]F(-) and [(18)F]FDG. Appl Radiat Isot. 2014 Jul; 89:167-75.
Score: 0.009
-
Synthesis and in vivo evaluation of N-ethylamino-2-oxo-1,2-dihydro-quinoline-3-carboxamide for inhibition of intestinal tumorigenesis in APC(Min/+) mice. Bioorg Med Chem Lett. 2014 Mar 01; 24(5):1380-2.
Score: 0.009
-
Raloxifene and antiestrogenic gonadorelin inhibits intestinal tumorigenesis by modulating immune cells and decreasing stem-like cells. Cancer Prev Res (Phila). 2014 Mar; 7(3):300-9.
Score: 0.009
-
Novel series of 111In-labeled bombesin analogs as potential radiopharmaceuticals for specific targeting of gastrin-releasing peptide receptors expressed on human prostate cancer cells. J Nucl Med. 2003 May; 44(5):823-31.
Score: 0.004
-
Radiochemical investigations of 177Lu-DOTA-8-Aoc-BBN[7-14]NH2: an in vitro/in vivo assessment of the targeting ability of this new radiopharmaceutical for PC-3 human prostate cancer cells. Nucl Med Biol. 2003 Feb; 30(2):101-9.
Score: 0.004